12th week of 2019 patent applcation highlights part 25 |
Patent application number | Title | Published |
20190085001 | AROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | 2019-03-21 |
20190085002 | NOVEL ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME | 2019-03-21 |
20190085003 | SILANE COMPOUND, RUBBER COMPOSITION AND TIRE | 2019-03-21 |
20190085004 | FLUORINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND COMPOUND | 2019-03-21 |
20190085005 | PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2019-03-21 |
20190085006 | Method For Producing Low Molecular Weight Aromatic Lignin-Derived Compounds | 2019-03-21 |
20190085007 | 4-methylcatechol Derivatives and Uses Thereof | 2019-03-21 |
20190085008 | NICOTINAMIDE RIBOSIDE AND NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENTS OF MITOCHONDRIAL-RELATED DISEASES | 2019-03-21 |
20190085009 | CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE | 2019-03-21 |
20190085010 | HCV POLYMERASE INHIBITORS | 2019-03-21 |
20190085011 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2019-03-21 |
20190085012 | 5'-Cyclo-Phosphonate Modified Nucleotides | 2019-03-21 |
20190085013 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | 2019-03-21 |
20190085014 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-03-21 |
20190085015 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-03-21 |
20190085016 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-03-21 |
20190085017 | 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY | 2019-03-21 |
20190085018 | DRUG COMPOUND AND PURIFICATION METHODS THEREOF | 2019-03-21 |
20190085019 | RAMAN TAG | 2019-03-21 |
20190085020 | Multi-Functional Chemical Agents, and the Method for Protein Modification | 2019-03-21 |
20190085021 | REMOVAL OF LEAKED AFFINITY PURIFICATION LIGAND | 2019-03-21 |
20190085022 | PEPTOID AFFINITY LIGANDS | 2019-03-21 |
20190085023 | CRYSTAL OF REDUCED GLUTATHIONE AND METHOD FOR PRODUCING SAME | 2019-03-21 |
20190085024 | Alpha-Ketoamide Inhibitors Of Cysteine Proteases | 2019-03-21 |
20190085025 | NOVEL COMPUNDS AND METHODS FOR INHIBITING CELL DEATH | 2019-03-21 |
20190085026 | AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2019-03-21 |
20190085027 | CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PREPARING SAME AND COMPOSITION THEREOF | 2019-03-21 |
20190085028 | SYNTHETIC PEPTIDES THAT MODULATE THE NMDA RECEPTOR | 2019-03-21 |
20190085029 | CYCLIN-DEPENDENT KINASE 5 (CDK5) INHIBITORY PEPTIDES | 2019-03-21 |
20190085030 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF | 2019-03-21 |
20190085031 | PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE, AND METHODS THEREOF | 2019-03-21 |
20190085032 | RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE | 2019-03-21 |
20190085033 | IMMUNOGENIC TRIMERS | 2019-03-21 |
20190085034 | ANTIBODY MIMIC CONJUGATES AND PARTICLES | 2019-03-21 |
20190085035 | SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES | 2019-03-21 |
20190085036 | Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same | 2019-03-21 |
20190085037 | NOVEL BACILLUS THURINGIENSIS GENE WITH LEPIDOPTERAN ACTIVITY | 2019-03-21 |
20190085038 | PLANT TRAITS CONFERRED BY ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES | 2019-03-21 |
20190085039 | Fluorescent Protein | 2019-03-21 |
20190085040 | PEPTIDE MODULATORS OF SPECIFIC CALCINEURIN PROTEIN-PROTEIN INTERACTIONS | 2019-03-21 |
20190085041 | SECRETORY PROTEIN | 2019-03-21 |
20190085042 | FUSION POLYPEPTIDE COMPRISING THE EXTRACELLULAR BINDING DOMAIN OF GROWTH HORMONE RECEPTOR | 2019-03-21 |
20190085043 | FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME | 2019-03-21 |
20190085044 | NOVEL THIOAMIDE-MODIFIED PEPTIDES AND USES THEREOF | 2019-03-21 |
20190085045 | METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA | 2019-03-21 |
20190085046 | HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS | 2019-03-21 |
20190085047 | ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS | 2019-03-21 |
20190085048 | MHC Multimers, Methods for Their Generation, Labeling and Use | 2019-03-21 |
20190085049 | Pulsed Introduction of Low-Dose RANKL as a Therapy for Diet-Induced Atherosclerosis | 2019-03-21 |
20190085050 | POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY | 2019-03-21 |
20190085051 | T1R TASTE RECEPTORS AND GENES ENCODING SAME | 2019-03-21 |
20190085052 | METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE | 2019-03-21 |
20190085053 | SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS | 2019-03-21 |
20190085054 | VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS | 2019-03-21 |
20190085055 | ENGINEERED IMMUNOGLOBULIN HEAVY CHAIN-LIGHT CHAIN PAIRS AND USES THEREOF | 2019-03-21 |
20190085056 | ANTIBODY-LIKE PEPTIDES FOR QUANTIFYING THERAPEUTIC ANTIBODIES | 2019-03-21 |
20190085057 | MAST CELL STABILIZERS FOR TREATMENT OF HYPERCYTOKINEMIA AND VIRAL INFECTION | 2019-03-21 |
20190085058 | DNA Antibody Constructs And Method Of Using Same | 2019-03-21 |
20190085059 | MYCOPLASMA PNEUMONIAE IMMUNOLOGICAL DETECTION METHOD AND KIT | 2019-03-21 |
20190085060 | CELL CULTURE ADDITIVES AND THEIR USE FOR INCREASED BIOPROTEIN PRODUCTION FROM CELLS | 2019-03-21 |
20190085061 | SELECTING HEADACHE PATIENTS RESPONSIVE TO ANTIBODIES DIRECTED AGAINST CALCITONIN GENE RELATED PEPTIDE | 2019-03-21 |
20190085062 | COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS | 2019-03-21 |
20190085063 | Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer | 2019-03-21 |
20190085064 | METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE | 2019-03-21 |
20190085065 | AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYOPIA OR HYPEROPIA | 2019-03-21 |
20190085066 | ANTIBODIES TO HGF AND COMPOSITIONS CONTAINING | 2019-03-21 |
20190085067 | COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION | 2019-03-21 |
20190085068 | IL-18 BINDING MOLECULES | 2019-03-21 |
20190085069 | Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses | 2019-03-21 |
20190085070 | ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND /OR FEVER | 2019-03-21 |
20190085071 | Antagonists to IL-6 to Raise Albumin and/or Lower CRP | 2019-03-21 |
20190085072 | Methods for Treating Visceral Pain by Administering Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide | 2019-03-21 |
20190085073 | HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF | 2019-03-21 |
20190085074 | Antibodies Towards an Extracellular Region of NBCn1 | 2019-03-21 |
20190085075 | LAG-3-Binding Molecules and Methods of Use Thereof | 2019-03-21 |
20190085076 | ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF | 2019-03-21 |
20190085077 | SIGLEC NEUTRALIZING ANTIBODIES | 2019-03-21 |
20190085078 | M971 CHIMERIC ANTIGEN RECEPTORS | 2019-03-21 |
20190085079 | CHIMERIC ANTIGEN RECEPTORS AND METHODS OF MAKING | 2019-03-21 |
20190085080 | B7-H4 ANTIBODIES AND METHODS OF USE THEREOF | 2019-03-21 |
20190085081 | CHIMERIC ANTIGEN RECEPTOR | 2019-03-21 |
20190085082 | ANTIBODIES AND RELATED MOLECULES AND USES THEREOF | 2019-03-21 |
20190085083 | KLRG1 SIGNALING THERAPY | 2019-03-21 |
20190085084 | ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF | 2019-03-21 |
20190085085 | ANTI-IL-6 RECEPTOR ANTIBODY | 2019-03-21 |
20190085086 | SCREENING METHODS FOR IDENTIFYING AND TREATING HIV-1 INFECTED PATIENT SUB-POPULATIONS SUITABLE FOR LONG TERM ANTI-CCR5 AGENT THERAPY | 2019-03-21 |
20190085087 | STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY | 2019-03-21 |
20190085088 | ANTI-CD40 ANTIBODIES AND USES THEREOF | 2019-03-21 |
20190085089 | ANTI-Ly6E ANTIBODIES AND METHODS OF USE | 2019-03-21 |
20190085090 | CROSS-LINKING POLYPEPTIDE THAT INDUCES APOPTOSIS | 2019-03-21 |
20190085091 | COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC | 2019-03-21 |
20190085092 | ANTI-SIALYL TN CHIMERIC ANTIGEN RECEPTORS | 2019-03-21 |
20190085093 | COMPOSITION FOR REGULATING CELL DIVISION COMPRISING FCHO1 MODULATOR, AND METHOD FOR REGULATING CELL DIVISION USING SAME | 2019-03-21 |
20190085094 | IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A | 2019-03-21 |
20190085095 | ANTI-C5 ANTIBODIES WITH ENHANCED PH SWITCH | 2019-03-21 |
20190085096 | ANTI-VWF D'D3 SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF | 2019-03-21 |
20190085097 | Specific Plasmin Inactivation by Anticatalytic Antibody | 2019-03-21 |
20190085098 | CELLULOSE ACETATE AEROGELS | 2019-03-21 |
20190085099 | Modification Initiator And Modified Conjugated Diene-based Polymer Including The Same | 2019-03-21 |
20190085100 | HYBRID SUPPORTED METALLOCENE CATALYST AND POLYOLEFIN PREPARATION METHOD USING SAME (As Amended) | 2019-03-21 |